196 related articles for article (PubMed ID: 34502529)
41. Antiproliferative and apoptosis induction of α-mangostin in T47D breast cancer cells.
Kritsanawong S; Innajak S; Imoto M; Watanapokasin R
Int J Oncol; 2016 May; 48(5):2155-65. PubMed ID: 26892433
[TBL] [Abstract][Full Text] [Related]
42. Oxidative stress-induced apoptosis is mediated by ERK1/2 phosphorylation.
Lee YJ; Cho HN; Soh JW; Jhon GJ; Cho CK; Chung HY; Bae S; Lee SJ; Lee YS
Exp Cell Res; 2003 Nov; 291(1):251-66. PubMed ID: 14597424
[TBL] [Abstract][Full Text] [Related]
43. Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling.
Atmaca H; Özkan AN; Zora M
Chem Biol Interact; 2017 Feb; 263():28-35. PubMed ID: 27989600
[TBL] [Abstract][Full Text] [Related]
44. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
45. Α-eleostearic acid inhibits growth and induces apoptosis in breast cancer cells via HER2/HER3 signaling.
Zhuo RJ; Wang F; Zhang XH; Zhang JJ; Xu J; Dong W; Zou ZQ
Mol Med Rep; 2014 Mar; 9(3):993-8. PubMed ID: 24425042
[TBL] [Abstract][Full Text] [Related]
46. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
[TBL] [Abstract][Full Text] [Related]
47. Antiangiogenic 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas Inhibit MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines Through PI3K/Akt and MAPK/Erk Pathways.
Machado VA; Peixoto D; Queiroz MJ; Soares R
J Cell Biochem; 2016 Dec; 117(12):2791-2799. PubMed ID: 27152982
[TBL] [Abstract][Full Text] [Related]
48. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.
Wang Z; Wang N; Han S; Wang D; Mo S; Yu L; Huang H; Tsui K; Shen J; Chen J
PLoS One; 2013; 8(7):e68566. PubMed ID: 23861918
[TBL] [Abstract][Full Text] [Related]
49. Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.
Garcia-Recio S; Fuster G; Fernandez-Nogueira P; Pastor-Arroyo EM; Park SY; Mayordomo C; Ametller E; Mancino M; Gonzalez-Farre X; Russnes HG; Engel P; Costamagna D; Fernandez PL; Gascón P; Almendro V
Cancer Res; 2013 Nov; 73(21):6424-34. PubMed ID: 24030979
[TBL] [Abstract][Full Text] [Related]
50. A novel 3',5'-diprenylated chalcone induces concurrent apoptosis and GSDME-dependent pyroptosis through activating PKCδ/JNK signal in prostate cancer.
Zhang Y; Yang J; Wen Z; Chen X; Yu J; Yuan D; Xu B; Luo H; Zhu J
Aging (Albany NY); 2020 May; 12(10):9103-9124. PubMed ID: 32427575
[TBL] [Abstract][Full Text] [Related]
51. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
[TBL] [Abstract][Full Text] [Related]
52. Tetramethoxychalcone, a chalcone derivative, suppresses proliferation, blocks cell cycle progression, and induces apoptosis of human ovarian cancer cells.
Qi Z; Liu M; Liu Y; Zhang M; Yang G
PLoS One; 2014; 9(9):e106206. PubMed ID: 25180593
[TBL] [Abstract][Full Text] [Related]
53. The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines.
Pozsgai E; Schally AV; Hocsak E; Zarandi M; Rick F; Bellyei S
Int J Oncol; 2011 Oct; 39(4):1025-32. PubMed ID: 21701777
[TBL] [Abstract][Full Text] [Related]
54. Simultaneous measurement of ERα, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry.
Bayraktar UD; Kim TK; Drews-Elger K; Benjamin C; El-Ashry D; Wieder E; Komanduri KV
Breast Cancer Res Treat; 2011 Sep; 129(2):623-8. PubMed ID: 21607585
[TBL] [Abstract][Full Text] [Related]
55. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.
Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M
Cell Oncol (Dordr); 2018 Feb; 41(1):61-72. PubMed ID: 29218545
[TBL] [Abstract][Full Text] [Related]
56. Human breast tumor cells are more resistant to cardiac glycoside toxicity than non-tumorigenic breast cells.
Clifford RJ; Kaplan JH
PLoS One; 2013; 8(12):e84306. PubMed ID: 24349570
[TBL] [Abstract][Full Text] [Related]
57. Flavokawain C Inhibits Cell Cycle and Promotes Apoptosis, Associated with Endoplasmic Reticulum Stress and Regulation of MAPKs and Akt Signaling Pathways in HCT 116 Human Colon Carcinoma Cells.
Phang CW; Karsani SA; Sethi G; Abd Malek SN
PLoS One; 2016; 11(2):e0148775. PubMed ID: 26859847
[TBL] [Abstract][Full Text] [Related]
58. Biphasic effect of arsenite on cell proliferation and apoptosis is associated with the activation of JNK and ERK1/2 in human embryo lung fibroblast cells.
He XQ; Chen R; Yang P; Li AP; Zhou JW; Liu QZ
Toxicol Appl Pharmacol; 2007 Apr; 220(1):18-24. PubMed ID: 17289100
[TBL] [Abstract][Full Text] [Related]
59. Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells.
Nunes-Xavier CE; Elson A; Pulido R
J Biol Chem; 2012 Jan; 287(5):3433-44. PubMed ID: 22117074
[TBL] [Abstract][Full Text] [Related]
60. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
